Trending...
- MileMark Explains Latest ABA Rules On Attorney Advertising
- Pikmykid Acquires Visitu to Enhance School Visitor Management Solutions
- Moonshot Announces 6th Annual 2025 Rural Arizona Pitch Competition Tour with Bilingual Resources and Mentors
TORONTO - JerseyDesk -- STS Capital Partners is proud to announce the appointment of Steve Slovick as a Managing Director in Puerto Rico. Throughout his 36-year career, Steve has demonstrated his expertise in pricing, commercial launch strategy, business development, market access, and exit strategies within the life science sector.
He started out as Senior Vice President in the early 2000's for PriceSpective, a consulting firm that specialized in strategies to identify, capture, and communicate value for products, portfolios, and companies in the biopharmaceutical industry. PriceSpective was acquired by ICON Plc, where Steve was an important part of the acquisition process unlocking the synergies between the two companies maximizing financial value. His knowledge aligns with our mission at STS Capital, which is centered on helping our clients achieve Extraordinary Exits.
Steve's entrepreneurial spirit led him to establish Jupiter Life Science Consulting in 2015. As CEO and Managing Partner, he led a dedicated team in providing commercial and market access strategies for global pharmaceutical, biotech, and medical device companies. His commitment to addressing complex market access challenges positioned Jupiter as a leading authority in the industry. In 2022, Jupiter was acquired by Red Nucleus where he stayed on as Managing Partner and President MACS to provide guidance and long-term partnership to life science clients worldwide.
More on Jersey Desk
Drawing from his firsthand experience of orchestrating successful exits, Steve offers a dual perspective as both a former business owner and a sell-side advisor. His comprehensive approach encompasses all aspects of the exit process, making him a valuable ally for business owners seeking a seamless transition.
Steve holds a Bachelor of Science in International Business and a Bachelor of Science in Marketing from the University of Colorado Boulder as well as a Master of Business Administration degree from Pepperdine Graziadio Business School.
"As a Managing Director at STS Capital Partners, Steve brings a wealth of experience and a track record of success to the table. With a career spanning decades, he has consistently demonstrated his ability to drive value and transformative initiatives within the pharmaceutical sector, aligning perfectly with our commitment to delivering maximum value and Extraordinary Exits for our clients." Sean Friday, CEO of STS Capital Partners.
About STS Capital Partners:
STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital.
More on Jersey Desk
Visit www.stscapital.com.
He started out as Senior Vice President in the early 2000's for PriceSpective, a consulting firm that specialized in strategies to identify, capture, and communicate value for products, portfolios, and companies in the biopharmaceutical industry. PriceSpective was acquired by ICON Plc, where Steve was an important part of the acquisition process unlocking the synergies between the two companies maximizing financial value. His knowledge aligns with our mission at STS Capital, which is centered on helping our clients achieve Extraordinary Exits.
Steve's entrepreneurial spirit led him to establish Jupiter Life Science Consulting in 2015. As CEO and Managing Partner, he led a dedicated team in providing commercial and market access strategies for global pharmaceutical, biotech, and medical device companies. His commitment to addressing complex market access challenges positioned Jupiter as a leading authority in the industry. In 2022, Jupiter was acquired by Red Nucleus where he stayed on as Managing Partner and President MACS to provide guidance and long-term partnership to life science clients worldwide.
More on Jersey Desk
- Pawganja Token: Redefining Cryptocurrency with Transparency and Philanthropy
- Investor Workshop at Mar-A-Lago, $27 Million for Acquisitions and Drug Treatment of Suicidal Depression: NRx Pharmaceuticals, Inc. (Stock S: NRXP)
- Upgraded Emergency Tech Keeps Owensboro Health Ahead During Winter Storm
- The Best Places to Go in Mexico in 2025
- Nayarit: Mexico's Best-Kept Secret for Fall and Winter Getaways in 2025
Drawing from his firsthand experience of orchestrating successful exits, Steve offers a dual perspective as both a former business owner and a sell-side advisor. His comprehensive approach encompasses all aspects of the exit process, making him a valuable ally for business owners seeking a seamless transition.
Steve holds a Bachelor of Science in International Business and a Bachelor of Science in Marketing from the University of Colorado Boulder as well as a Master of Business Administration degree from Pepperdine Graziadio Business School.
"As a Managing Director at STS Capital Partners, Steve brings a wealth of experience and a track record of success to the table. With a career spanning decades, he has consistently demonstrated his ability to drive value and transformative initiatives within the pharmaceutical sector, aligning perfectly with our commitment to delivering maximum value and Extraordinary Exits for our clients." Sean Friday, CEO of STS Capital Partners.
About STS Capital Partners:
STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital.
More on Jersey Desk
- How One Mom is Revolutionizing Sleep with a Groundbreaking Weighted Blanket
- LIB: A master of ingenuity in the field of custom test chambers, unlocking unlimited possibilities!
- PRP Aviation Earns Prestigious "Platinum Cirrus Training Center" Designation
- Celebrate Dry Or Damp January At Ludlam Island Brewery
- The Craig School Celebrates 45 Years with a Grant Award from The Summit Foundation to Enhance Classroom Accessibility
Visit www.stscapital.com.
Source: STS Capital Partners
Filed Under: Business
0 Comments
Latest on Jersey Desk
- MileMark Explains Latest ABA Rules On Attorney Advertising
- The Annual Kingdom Day Parade Celebrates 40th Anniversary With Its " 40th Annual Kingdom Day Parade"
- WeGetFinancing Reports Impressive 2024 Results with 31% Increase in Funded Transactions
- Morningscore Secures $700k in Funding to Build the Next Generation of AI SEO and Expand Globally
- Certified Nutraceuticals Partners with Colorado Researchers for Groundbreaking Study on KollaJell™ and Brain Health
- GD Nationwide: 2024 Recap and 2025 Preview
- Preserving Mikaben's Legacy: A Plea For Unity And Respect
- Globally-renowned scholar Dalia Mogahed Joins Origins Consulting Group as Senior Adviser on Islamophobia
- Agreement for $27 Million in Funding for Expanding Clinic Acquisitions and Operations,: NRx Pharmaceuticals, Inc. Stock Symbol: NRXP)
- Author and Speaker El-Hajj Maurice Crawford Shabazz Releases New Book
- Newly formed Dave Aronberg Law taps Assistant U.S. Attorney Emily M. Walters as Partner
- USA Green Card Defends the Green Card Lottery as Vital to Opportunity and Diversity
- Watchdog Reviews Milestones in Exposing Psychiatric Human Rights Abuses in 2024
- Crow Wear Takes Flight: A New Clothing Brand Inspired by the Intelligence and Resilience of Crows
- The Nashville International Chopin Piano Competition Announces Its Second Edition
- Shostakovich @50: Adelphi Orchestra Presents World Premiere and Symphonic Masterpieces
- Avoid the Quitter's Day Trap this January 10th by Adopting an Ingenious Method Used by Basketball Legend LeBron James: Wear an "I Promise" Wristband
- The Center for Contemporary Art Offers Winter Art Classes for Adults, Teens & Children
- The Trends Journal's Top Trends of 2025
- Acmeware and Interlace Health Join Forces to Revolutionize Downtime Solutions